We are live on ! Find out more
VIVS

VivoSim Labs

46 hedge funds and large institutions have $40M invested in VivoSim Labs in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more capital invested

Capital invested by funds: $25.9M → $40M (+$14.1M)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

0% more funds holding

Funds holding: 4646 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

0.16% less ownership

Funds ownership: 4.18%4.02% (-0.16%)

Holders
46
Holders Change
Holders Change %
0%
% of All Funds
0.81%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
8
Reduced
7
Closed
9
Calls
$912K
Puts
Net Calls
+$912K
Net Calls Change
+$140K

VIVS Hedge Fund Activity: Q4 2020 in Review

46 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q4 2020, worth a combined $40M — up 54% from $25.9M a quarter earlier.

Fund positioning in VIVS was balanced in Q4 2020: 9 funds opened new positions, 9 closed out, 8 added to existing stakes and 7 trimmed.

The largest buyer was UBS Group, adding an estimated $297K. The largest seller was Renaissance Technologies, cutting an estimated $427K.

  • 46 institutional investors held VivoSim Labs (VIVS) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $40M of VivoSim Labs stock for Q4 2020, up 54% quarter-over-quarter.
  • 9 funds opened new VivoSim Labs positions in Q4 2020 and 9 closed out, a net change of 0 holders.
  • The largest VivoSim Labs buyer in Q4 2020 was UBS Group, an estimated $297K added.
  • The largest VivoSim Labs seller in Q4 2020 was Renaissance Technologies, an estimated $427K sold.

Based on aggregated 13F filings for Q4 2020.